Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In Neuromuscular Disorders
Neuromuscular Disorders for November/December 2017
FDA Approves Soliris for Generalized MG, Alexion news release; 2017 Oct 23
Neuromuscular Disorders for September/October 2017
Immune Changes in ALS Bear Closer Observation, JAMA Neurol; ePub 2017 Sep 25; Murdock, et al
Neuromuscular Disorders for January/February 2017
FDA Approves Drug to Treat Duchenne MD, FDA news release; 2017 Feb 9
Trigeminal Neuralgia Often Precedes MS Diagnosis, Int J MS Care; ePub 2017 Jan 31; Fallata, et al
Agent in Well Water, Motor Neuron Disease Linked, Amyotroph Lateral Scler Frontotemporal Degener; ePub 2016 Dec 25; Schwartz, et al
FDA Approves Spinraza, First Drug for SMA , FDA news release, 2016 Dec 23
Neuromuscular Disorders for November/December 2016
Polyneuropathy High in Obese Individuals, JAMA Neurol; ePub 2016 Oct 31; Callaghan, et al
Antioxidant Foods, Higher ALS Function Linked, JAMA Neurology; ePub 2016 Oct 24; Nieves, et al
Higher ALS Rates, Race/Ethnicity Examined, Neurology; ePub 2016 Oct 14; Roberts, et al
Neuromuscular Disorders for September/October 2016
FDA Grants Approval for First Drug for Duchenne MD, Sarepta Therapeutics news release; 2016 Sep 19
MRI Measure of Cerebral Peduncle Angle Unreliable, Parkinsonism Relat Disord; ePub 2016 Aug 11; Tipton, et al
MRI Measure of Cerebral Peduncle Angle Unreliable, Parkinsonism Relat Disord; ePub 2016 Aug 11; Tipton, et al